Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?
Lancet Diabetes Endocrinol · 2020
Last updated 2026-05-28| Journal | Lancet Diabetes Endocrinol, 2020 |
|---|---|
| Citations | 4 |
| Relative citation ratio | 0.17 |
| NIH percentile | 11 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Chronic Kidney Disease |
Full record and abstract on PubMed 32971039 ↗